×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TSBX – turnstone biologics corp. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TSBX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
08:27 am
tsbx
Turnstone Biologics Corp. (NASDAQ: TSBX) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Medium
Report
Turnstone Biologics Corp. (NASDAQ: TSBX) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
11/12
04:05 pm
tsbx
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Medium
Report
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
11/5
09:05 am
tsbx
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting [Yahoo! Finance]
Low
Report
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting [Yahoo! Finance]
11/5
09:01 am
tsbx
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Low
Report
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
10/14
07:56 am
tsbx
Turnstone Biologics Corp. (NASDAQ: TSBX) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.
Low
Report
Turnstone Biologics Corp. (NASDAQ: TSBX) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.
10/11
06:00 am
tsbx
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Low
Report
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Date
Time
Symbol
Company Name
Action
%Chg
3/21/2024
05:06 pm
TSBX
turnstone biologics corp.
BEAT
Report
-10.5%
turnstone biologics corp.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:21 pm
tsbx
Form 10-Q Turnstone Biologics Corp For: Sep 30
Medium
Report
Form 10-Q Turnstone Biologics Corp For: Sep 30
11/12
04:08 pm
tsbx
Form 8-K Turnstone Biologics Corp For: Nov 12
Medium
Report
Form 8-K Turnstone Biologics Corp For: Nov 12
10/11
06:16 am
tsbx
Form 8-K Turnstone Biologics Corp For: Oct 09
Low
Report
Form 8-K Turnstone Biologics Corp For: Oct 09
10/1
04:41 pm
tsbx
Form 8-K Turnstone Biologics Corp For: Sep 27
Medium
Report
Form 8-K Turnstone Biologics Corp For: Sep 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: